Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection. - Institut Pasteur Access content directly
Journal Articles Cell Reports Year : 2017

Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection.

Fadel Sayes
Alexandre Pawlik
Roxane Simeone

Abstract

Recent insights into the mechanisms by which Mycobacterium tuberculosis, the etiologic agent of human tuberculosis, is recognized by cytosolic nucleotide sensors have opened new avenues for rational vaccine design. The only licensed anti-tuberculosis vaccine, Mycobacterium bovis BCG, provides limited protection. A feature of BCG is the partial deletion of the ESX-1 type VII secretion system, which governs phagosomal rupture and cytosolic pattern recognition, key intracellular phenotypes linked to increased immune signaling. Here, by heterologously expressing the esx-1 region of Mycobacterium marinum in BCG, we engineered a low-virulence, ESX-1-proficient, recombinant BCG (BCG::ESX-1(Mmar)) that induces the cGas/STING/TBK1/IRF-3/type I interferon axis and enhances AIM2 and NLRP3 inflammasome activity, resulting in both higher proportions of CD8(+) T cell effectors against mycobacterial antigens shared with BCG and polyfunctional CD4(+) Th1 cells specific to ESX-1 antigens. Importantly, independent mouse vaccination models show that BCG::ESX-1(Mmar) confers superior protection relative to parental BCG against challenges with highly virulent M. tuberculosis.
Fichier principal
Vignette du fichier
BCG-marinum-resolution-reduit.pdf (1.95 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

pasteur-01503927 , version 1 (07-04-2017)

Licence

Attribution - NonCommercial - NoDerivatives

Identifiers

Cite

Matthias I Gröschel, Fadel Sayes, Sung Jae Shin, Wafa Frigui, Alexandre Pawlik, et al.. Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection.. Cell Reports, 2017, 18 (11), pp.2752-2765. ⟨10.1016/j.celrep.2017.02.057⟩. ⟨pasteur-01503927⟩

Collections

PASTEUR ANR FRM
241 View
365 Download

Altmetric

Share

Gmail Facebook X LinkedIn More